Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter [...]

CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ:HLCS - News) today announced the shipment of a Helicos™ Genetic Analysis System to Stanford University for use in research. The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that [...]

Pharsight Expands Global Presence Through InforSense Chinese Distributor, Companies to Collaborate On Use of Biomarkers in PK/PD Modeling MOUNTAIN VIEW, Calif., and LONDON, Oct 7, 2008 -- Pharsight Corporation, a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and InforSense Ltd., the leading provider of next-generation business and scientific [...]

Cytori Therapeutics (NASDAQ: CYTX) received two Notices of Allowance from the U.S. Patent & Trademark Office for patents, which cover methods related to the Celution(R) System output. These patent allowances add specific commercial applications to U.S. Patent No. 7,390,484, issued in June 2008, which covers the Celution System technology that processes adipose-derived stem and regenerative [...]

Invitrogen Corporation (NASDAQ:IVGN) today announced that it has filed the necessary formal notification to the European Commission with respect to its pending acquisition of Applied Biosystems Inc. (NYSE:ABI). Under European Commission rules, the Commission has 25 business days following the date of notification to respond to the filing. The company continues to expect the transaction [...]

Technology expected to aid drug discovery by allowing for the rapid synthesis of molecules using a single reaction ST. LOUIS, Oct. 7 -- Sigma-Aldrich (Nasdaq: SIAL - News) is pleased to announce that it has signed an exclusive licensing agreement with the University of Illinois at Urbana-Champaign allowing Sigma-Aldrich to offer research quantities of powerful [...]

Affymetrix Inc., (Nasdaq:AFFX) today announced that one of South Africa's largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, [...]

NEWTON, Mass.--Microfluidics, a division of Microfluidics International Corporation (OTCBB: MFLU), announces the availability of several new services designed to enhance customer success and assist in customer innovation. These new services build on the deep technology, process and applications expertise that Microfluidics has developed through its 25 years of experience with thousands of customer applications, including [...]

Heidolph Brinkann LLC (Elk Grove, IL) have announced a new option for the Radleys Lara Controlled Laboratory Reactor (CLR) system and bespoke Laboratory Reactors that offers chemists studying crystal morphology significant benefits. Traditionally chemists have used video microscopy as their technique of choice for non-invasive monitoring of particle shape, shape and quantity in process. Radleys [...]

NEWBURY PARK, Calif.--Electronic Sensor Technology (EST) (OTCBB:ESNR), a leading provider of innovative ultra high-speed instrumentation for the homeland security, environmental, flavors and fragrance industries, today announced that it has entered into an exclusive distribution agreement with Stetsonex International Company (SIC) to distribute EST’s products in Western Africa. Steve Olaye, President of SIC, a leading supplier [...]